Clinical Trials on Cord Blood in Australia

Total 4274 results

Royal Perth Hospital
ReCor Medical, Inc.

Recruiting

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. (RESURRECT)

Heart Failure | Chronic Kidney Diseases | End Stage Renal Disease

Australia
Western Sydney Local Health District

Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT)

Ventricular Tachycardia | Cardiomyopathy, Dilated | Heart Disease Structural Disorder | Sarcoidosis | Cardiomyopathy, Hypertrophic | Cardiomyopathy, Familial | Cardiomyopathy Ischemic | Arrhythmogenic Right Ventricular Cardiomyopathy 1 | Arrhythmogenic Left Ventricular Cardiomyopathy

Australia
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
GlaxoSmithKline

Completed

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Healthy Subjects | Anaemia

Australia
ImpediMed Limited

Completed

The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device

Lymphedema

Australia
Flinders University

Recruiting

Role of Perhexiline in Hypertrophic Cardiomyopathy (RESOLVE-HCM)

Hypertrophic Cardiomyopathy

Australia
Marinomed Biotech AG

Completed

Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses

Common Cold | Viral Infection

Austria
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
South Eastern Sydney Local Health District
GlaxoSmithKline

Unknown

The International ITP Registry

Thrombocytopenia

Singapore, Korea, Republic of, Thailand, Turkey, Australia, Colombia, Kuwait, Malaysia, Taiwan, Uruguay
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Spain, Australia, Denmark, Norway
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Australia
Medical University of Vienna

Unknown

Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease (ASA-COPD)

COPD

Austria
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
The Alfred

Completed

Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Statin Withdrawal Study

Heart Failure

Australia
Cancer Trials Australia
Human Genome Sciences Inc.

Unknown

A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Symptomatic Waldenstroms Macroglobulinaemia

Australia
The George Institute
National Health and Medical Research Council, Australia; New South Wales Health and other collaborators

Completed

Changing Population Salt Consumption in Lithgow, Australia

Hypertension | Cardiovascular Disease | Blood Pressure

Australia
Cardiosonic

Unknown

Continued Safety and Performance of the TIVUS System

Hypertension, Resistant to Conventional Therapy

Australia
Novartis

Completed

Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension

Ocular Hypertension

Australia
Cynata Therapeutics Limited

Active, not recruiting

Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers

Diabetic Foot Ulcer | Cutaneous Ulcer

Australia
King Edward Memorial Hospital
The University of Western Australia

Unknown

Prevention of Pre-Term Birth by Treatment of Periodontal Disease

Periodontal Diseases | Premature Birth | Pre-Eclampsia

Australia
Gilead Sciences

Terminated

Efficacy Study of CYT997 in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma

Australia
Aerami Therapeutics

Completed

Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

Pulmonary Arterial Hypertension

Australia
Bayside Health
National Health and Medical Research Council, Australia; Monash University

Recruiting

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery (ITACS)

Anaemia

Australia
Presage Biosciences
Takeda

Withdrawn

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Solid Tumour

Australia
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
Flinders University
Flinders Medical Centre; Lyell McEwin Hospital

Recruiting

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (MIICI)

Myocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint Inhibitors

Australia
Boston Scientific Corporation

Completed

REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm (REPRISE I)

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

Australia
Bayer

Terminated

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Hemophilia A and B

Australia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
Australasian Leukaemia and Lymphoma Group

Recruiting

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure. (GOlDiLOX)

Mantle Cell Lymphoma | Mantle Cell Lymphoma Refractory

Australia
Peter MacCallum Cancer Centre, Australia
Janssen-Cilag Ltd.

Completed

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

Multiple Myeloma

Australia
Baker Heart and Diabetes Institute

Completed

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Hypertension

Australia
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Hypertension

Australia
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Sulfagenix Australia Pty Ltd.

Completed

Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients

Heart Failure

Australia
Monash University
National Health and Medical Research Council, Australia

Completed

SCREEN-HFL (SCReening Evaluation of the Evolution of New Heart Failure) - a Longitudinal Study (SHF-L)

Heart Failure

Australia
Ingrid Hopper
HBA

Completed

Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)

Heart Failure

Australia
Monash University

Completed

Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers

Heart Failure

Australia
Royal Hobart Hospital

Unknown

U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis

Haemodialysis

Australia
Bristol-Myers Squibb

Completed

Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects

Atherosclerosis

Australia
Massachusetts General Hospital
Sir Charles Gairdner Hospital

Completed

Midodrine for the Treatment of Refractory Hypotension

Critical Illness | Hypotension

United States, Australia
Baker Heart and Diabetes Institute

Recruiting

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

Heart Failure

Australia
Bayside Health
Monash University

Completed

Association of Postoperative Anaemia With Patient-centred Outcomes

Anemia After Surgery

Australia
The Alfred

Completed

Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure

Heart Failure

Australia
The Alfred

Completed

Digoxin Withdrawal in Stable Heart Failure

Heart Failure

Australia
Monash University
National Heart Foundation, Australia

Completed

SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)

Heart Failure

Australia
Abbott Medical Devices

Completed

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension (EnligHTN III)

Hypertension | Renal Denervation

New Zealand, Australia
Prof Henry Krum
HD Medical Group Ltd

Terminated

Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools

Cardiovascular Diseases

Australia
AbbVie

Withdrawn

A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Multiple Myeloma

Australia
TetraLogic Pharmaceuticals

Terminated

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

Hepatitis B

Australia
Peter MacCallum Cancer Centre, Australia

Completed

Panobinostat Biological Correlates Study (VEG VCA1)

Multiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With Lymphoma

Australia

Clinical Trials on Cord Blood in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations